Differentiation potential of human retinoblastoma cells

Current Pharmaceutical Biotechnology

Volumn 12, Issue 2, 2011, Pages 213-216

  Seigel, Gail M ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Cancer stem cell; Differentiation; Glia; Neurons; Retinoblastoma

Indexed keywords

BETA TUBULIN; BREAST CANCER RESISTANCE PROTEIN; BUTYRIC ACID; CONCANAVALIN A; MICROTUBULE ASSOCIATED PROTEIN 2; NEURON SPECIFIC ENOLASE; PIGMENT EPITHELIUM DERIVED FACTOR; RETINOIC ACID; SYNAPTOPHYSIN;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL STRUCTURE; CELL SUBPOPULATION; HUMAN; METASTASIS; NONHUMAN; PHENOTYPIC VARIATION; RETINOBLASTOMA; TUMOR CELL; TUMOR CELL LINE;

EID: 79551649389     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111794295846     Document Type: Article

References (52)

1. Devesa, S. S. The incidence of retinoblastoma. Am. J. Ophthalmol., 1975, 80, 263-265.
2. Pendergrass, T. W.; Davis S. Incidence of retinoblastoma in the United States. Arch. Ophthalmol., 1980, 98, 1204-1210.
3. Knudson, A.G. Jr. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 1971, 68(4), 820-823.
4. Stovall, F.; Li, P.; Fraumeni, J.F. Jr. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J. Clin. Oncol., 2005, 23, 2272-2279.
5. Matsunaga, E. Hereditary retinoblastoma: host resistance and second primary tumors. J. Natl. Cancer Inst., 1980, 65(1), 47-51.
6. Draper, G.J.; Sanders, B.M.; Brownbill, P.A.; Hawkins, M.M. Patterns of risk of hereditary retinoblastoma and applications to genetic counselling. Br. J. Cancer, 1992, 66, 211-219.
7. Pardal, R.; Clarke M.F.; Morrison, S.J. Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer, 2003, 3, 895-902.
8. Kleinerman, R. A.; Tucker, M. A.; Tarone R. E.; Abramson, D. H.; Seddon, J. M.; Reya, T.; Morrison, S. J.; Clarke, M. F.; Weissman, I.L. Stem cells, cancer, and cancer stem cells. Nature, 2001, 414, 105-111.
9. Bonnet, D.; Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med., 1997, 3, 730-737.
10. Lapidot, T.; Sirard, C.; Vormoor, J.; Murdoch, B.; Hoang, T.; Caceres-Cortes, J.; Minden, M; Paterson, B.; Caligiuri, M.A.; Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 1994, 367, 645-648.
11. Al-Hajj, M.; Wicha, M. S.; Benito-Hernandez, A.; Morrison, S. J.; Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA, 2003, 100, 3983-3988.
12. Singh, S. K.; Clarke, I. D.; Terasaki, M.; Bonn, V. E.; Hawkins, C.; Squire, J.; Dirks, P. B. Identification of a cancer stem cell in human brain tumors. Cancer Res., 2003, 63, 5821-5828.
13. Kondo, T.; Setoguchi, T.; Taga. T. Persistence of a small subpopulation of cancer stemlike cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. USA, 2004, 101,781-786.
14. Seigel, G. M.; Campbell, L. M.; Narayan, M.; Gonzalez-Fernandez, F. Cancer stem cell characteristics in retinoblastoma. Mol. Vis., 2005, 11, 729-737.
15. Seigel, G. M.; Hackam, A.; Ganguly, A.; Gonzalez-Fernandez, F. Embryonic and neuronal stem cell markers in retinoblastoma. Mol. Vis., 2007, 13, 823-832.
16. Kim, M.; Kim, J. H.; Kim, J. H.; Kim, D. H.; Yu, Y. S. Differential expression of stem cell markers and vascular endothelial growth factor in human retinoblastoma tissue. Kor. J. Ophthalmol., 2010, 24(1), 35-39.
17. Silva, A. K.; Hyun, Y.; Hayes, S. H.; Seigel, G. M.; Hackam, A. S. Lithium chloride regulates the proliferation of stem-like cells in retinoblastoma cell lines: a potential role for the canonical Wnt signaling pathway. Mol. Vis., 2010, 16, 36-45.
18. Zhong, X.; Li Y.; Peng, F.; Huang, B.; Lin, J.; Zhang, W.; Zheng, J.; Jiang, R.; Song, G.; Ge, J. Identification of tumorigenic retinal stem-like cells in human solid retinoblastomas. Int. J. Cancer, 2007, 121, 2125-2131.
19. Reid, T. W.; Albert, D. M.; Rabson, A. S.; Russell, P.; Craft, J.; Chu, E. W.; Tralka, T. S.; Wilcox, J. L. Characteristics of an established cell line of retinoblastoma. J. Natl. Cancer Inst., 1974, 53(2), 347-360.
20. Sery, T. W.; Lee, E. Y.; Lee, W. H.; Bookstein, R.; Wong, V.; Shields, J. A.; Augsburger, J. J.; Donoso, L. A. Characteristics of two new retinoblastoma cell lines: WERI-Rb24 and WERI-Rb27. J. Pediatr. Ophthalmol. Strabismus., 1990, 27(4), 212-217.
21. McFall, R. C.; Sery, T. W.; Makadon, M. Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res., 1977, 37(4), 1003-1010.
22. Jiang, Q.; Lim, R.; Blodi, F. C. Dual properties of cultured retinoblastoma cells: immunohistochemical characterization of neuronal and glial markers. Exp. Eye Res., 1984, 39(2), 207-215.
23. Kyritsis, A. P.; Tsokos, M.; Triche, T. J.; Chader, G. J. Retinoblastoma-- origin from a primitive neuroectodermal cell? Nature, 1984, 307(5950), 471-473.
24. Dyer, M.; Bremner, R. The search for the retinoblastoma cell of origin, Nat. Rev. Cancer, 2005, 5, 91-101.
25. Stephan, H.; Zakrzewski, J. L.; Bölöni, R.; Grasemann, C.; Lohmann, D. R.; Eggert, A. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines. Pediatr. Blood Cancer, 2008, 50(2), 218-222.
26. Donoso, L. A.; Hamm, H.; Dietzschold, B.; Augsburger, J. J.; Shields, J. A.; Arbizo, V. Rhodopsin and retinoblastoma. A monoclonal antibody histopathologic study. Arch. Ophthalmol., 1986, 104(1), 111-113.
27. Perentes, E.; Herbort, C. P.; Rubinstein, L. J.; Herman, M. M.; Uffer, S.; Donoso, L. A.; Collins, V. P. Immunohistochemical characterization of human retinoblastomas in situ with multiple markers. Am. J. Ophthalmol., 1987, 103(5), 647-645.
28. Ts'o, M. O.; Fine, B. S.; Zimmerman, L. E. The nature of retinoblastoma. II. Photoreceptor differentiation: an electron microscopic study. Am. J. Ophthalmol., 1970, 69(3), 350-359.
29. Sun, X. L.; Yokoyama, T.; Minoda, K.; Sakuma, A. Immunohistochemical studies of retinoblastoma. Jpn. J. Ophthalmol., 1990, 34(2), 149-157.
30. Shuangshoti, S.; Chaiwun, B.; Kasantikul, V. A study of 39 retinoblastomas with particular reference to morphology, cellular differentiation and tumour origin. Histopathology, 1989, 15(2), 113-124.
31. Schrøder, H. D. Immunohistochemical demonstration of glial markers in retinoblastomas. Virchows Arch. A Pathol. Anat. Histopathol., 1987, 411(1), 67-72.
32. Kyritsis, A.; Joseph, G.; Chader, G. J. Effects of butyrate, retinol, and retinoic acid on human Y-79 retinoblastoma cells growing in monolayer cultures. J. Natl. Cancer Inst., 1984, 73(3), 649-654.
33. Kyritsis, A.; Tsokos, M.; Chader, G. Attachment culture of human retinoblastoma cells: long-term culture conditions and effects of dibutyryl cyclic AMP. Exp. Eye Res., 1984, 38(4), 411-421.
34. Kyritsis, A. P.; Tsokos, M.; Triche, T. J.; Chader, G. J. Retinoblastoma: a primitive tumor with multipotential characteristics. Invest. Ophthalmol. Vis. Sci., 1986, 27(12),1760-1764.
35. Kyritsis, A. P.; Fletcher, R. T.; Chader, G. J. Laminin: an initiating role in retinoblastoma cell attachment and differentiation. In Vitro. Cell Dev. Biol., 1986, 22(7), 418-422.
36. Tsokos, M.; Kyritsis, A. P.; Chader, G. J.; Triche, T. J. Differentiation of human retinoblastoma in vitro into cell types with characteristics observed in embryonal or mature retina. Am. J. Pathol., 1986, 123(3), 542-552.
37. Kyritsis, A. P.; Wiggert, B.; Lee, L.; Chader, G. J. Butyrate enhances the synthesis of interphotoreceptor retinoid-binding protein (IRBP) by Y-79 human retinoblastoma cells. J. Cell. Physiol., 1985, 124(2), 233-239.
38. Wiechmann, A.F. Recoverin in cultured retinoblastoma cells: enhanced expression during morphological differentiation. J. Neurochem., 1996, 67 (1), 105-110.
39. Monsma, F. J.; Barton, A. C.; Sibley, D. Differentiation of functional D2 dopamine receptors following differentiation of Y79 human retinoblastoma cells. J. Neurochem., 1990, 54(4), 1200-1207.
40. del Cerro, M.; Notter, M. F. D.; Seigel, G.; Lazar, E.; Chader, G.; del Cerro, C. Intraretinal xenografts of differentiated human retinoblastoma cells integrate with the host retina. Brain Res., 1992, 583(1-2), 12-22.
41. del Cerro, M.; Seigel, G. M.; Lazar, E.; Grover, D.; del Cerro, C.; Brooks, D. H.; DiLoreto, D Jr.; Chader, G. Transplantation of Y79 cells into rat eyes: an in vivo model of human retinoblastomas. Invest. Ophthalmol. Vis. Sci., 1993, 34(12), 3336-3346.
42. Ajioka, I.; Martins, R. A.; Bayazitov, I. T.; Donovan, S.; Johnson, D. A.; Frase, S.; Cicero, S. A.; Boyd, K.; Zakharenko, S. S.; Dyer, M. A. Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice. Cell, 2007, 131(2), 378-390.
43. Herman, M. M.; Perentes, E.; Katsetos, C. D.; Darcel, F.; Frankfurter, A.; Collins, V. P.; Donoso, L. A.; Eng, L. F.; Marangos, P. J.; Weichman, A. F.; May, E. E.; Thomas, C. B.; Rubinstein, L. J. Neuroblastic differentiation potential of the human retinoblastoma cell lines Y79 and WERI-RB1 maintained in an organ culture system. Am. J. Pathol., 1989, 134, 115-132.
44. Bogenmann, E. Retinoblastoma cell differentiation in culture. Int. J. Cancer, 1986, 38(6), 883-887.
45. Tombran-Tink, J.; Chader, G.J.; Johnson, L.V. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp. Eye Res., 1991, 53(3), 411-414.
46. Steele, F. R.; Chader, G. J.; Johnson, L.V.; Tombran-Tink, J. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc. Natl. Acad. Sci. USA, 1993, 90(4), 1526-1530.
47. Becerra, S. P.; Palmer, I.; Kumar, A.; Steele, F.; Shiloach, J.; Notario, V.; Chader, G. J. Overexpression of fetal human pigment epithelium- derived factor in Escherichia coli. A functionally active neurotrophic factor. J. Biol. Chem., 1993, 268(31), 23148-23156.
48. Seigel, G. M.; Tombran-Tink, J.; Becerra, S. P.; Chader, G. J.; Diloreto, D. A. Jr.; del Cerro, C.; Lazar, E. S.; del Cerro, M. Differentiation of Y79 retinoblastoma cells with pigment epithelialderived factor and interphotoreceptor matrix wash: effects on tumorigenicity. Growth Factors, 1994, 10(4), 289-297.
49. Mannino, R. J.; Burger, M. Growth inhibition of animals cells by succinylated concanavalin A. Nature, 1975, 256, 19-22.
50. Mannino, R. J.; Ballmer, K.; Keltner, D.; Burger, M. Growth inhibition of transformed cells with succinylated concanavalin A. Science, 1978, 201, 824-826.
51. Seigel, G. M.; Notter, M. F. Differentiation of Y79 retinoblastoma cells induced by succinylated concanavalin A. Cell Growth Differ., 1993, 4, 1-7.
52. Seigel, G. M. Evidence for Cancer Stem Cells in Retinoblastoma in Cancer Stem Cells; Wiley and sons: USA, 2008, pp. 87-94.